Explore / Clinical trial
Clinical trial

Spreading Depolarization and Ketamine Suppression

University of New MexicoCompletedPhase 1Started Jul 1, 201510 enrolledUnited StatesNCT02501941

Abstract

Hypothesis: Cortical spreading depolarizations are inhibited by the NMDA receptor antagonist Ketamine Aim 1: To demonstrate, in a group of patients with acute severe brain injury requiring surgery including traumatic brain injury and aneurysmal subarachnoid hemorrhage, whether use of continuous infusion of ketamine decreases frequency of occurrence of cortical spreading depolarizations.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

Cortical Spreading DepolarizationCortical Spreading DepressionCortical Spreading DepolarizationCortical Spreading DepressionSubarachoid HemorrhageTraumatic Brain Injury

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.